Literature DB >> 16810119

Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.

Susan H Eshleman, Jessica D Church, Shu Chen, Laura A Guay, Anthony Mwatha, Susan A Fiscus, Francis Mmiro, Philippa Musoke, Newton Kumwenda, J Brooks Jackson, Taha E Taha, Donald R Hoover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16810119     DOI： 10.1097/01.qai.0000221676.22069.b8

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  9 in total

1.  Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.

Authors:  Bhavna H Chohan; Kenneth Tapia; Sarah Benki-Nugent; Brian Khasimwa; Musa Ngayo; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Julie Overbaugh; Grace John-Stewart
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-22       Impact factor: 2.205

2.  Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants.

Authors:  Ceejay L Boyce; Tatiana Sils; Daisy Ko; Annie Wong-On-Wing; Ingrid A Beck; Sheila M Styrchak; Patricia DeMarrais; Camlin Tierney; Lynda Stranix-Chibanda; Patricia M Flynn; Taha E Taha; Maxensia Owor; Mary Glenn Fowler; Lisa M Frenkel
Journal:  Clin Infect Dis       Date:  2022-06-10       Impact factor: 20.999

3.  Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Viruses       Date:  2010-11-11       Impact factor: 5.048

Review 4.  Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Authors:  Kajal Buckoreelall; Tim R Cressey; Jennifer R King
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 5.577

Review 5.  Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.

Authors:  Omayma Amin; Jenna Powers; Katherine M Bricker; Ann Chahroudi
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

6.  Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.

Authors:  Tim R Cressey; Hannah Green; Saye Khoo; Jean-Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M Gibb; David M Burger
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

7.  The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Mol Biol Int       Date:  2012-06-26

8.  HIV-1 Genetic Variability and Clinical Implications.

Authors:  Maria Mercedes Santoro; Carlo Federico Perno
Journal:  ISRN Microbiol       Date:  2013-06-17

9.  Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.

Authors:  Camille Ndondoki; Fatoumata Dicko; Patrick Ahuatchi Coffie; Tanoh Kassi Eboua; Didier Koumavi Ekouevi; Kouakou Kouadio; Addi Edmond Aka; Karen Malateste; François Dabis; Clarisse Amani-Bosse; Pety Toure; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2014-06-02       Impact factor: 5.396
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.